Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
227 SEK | -1.09% | -4.22% | +7.08% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 782M 72.45M | Sales 2025 * | 889M 82.28M | Capitalization | 5.47B 507M |
---|---|---|---|---|---|
Net income 2024 * | 172M 15.93M | Net income 2025 * | 217M 20.09M | EV / Sales 2024 * | 6.82 x |
Net cash position 2024 * | 138M 12.75M | Net cash position 2025 * | 212M 19.66M | EV / Sales 2025 * | 5.92 x |
P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
25.2
x | Employees | - |
Yield 2024 * |
1.08% | Yield 2025 * |
1.31% | Free-Float | 61.96% |
Latest transcript on CellaVision AB
1 day | -0.43% | ||
1 week | +1.10% | ||
Current month | +1.77% | ||
1 month | +3.61% | ||
3 months | -11.73% | ||
6 months | +34.68% | ||
Current year | +8.25% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 227 | -1.09% | 1 653 |
24-05-14 | 229.5 | -0.43% | 11,783 |
24-05-13 | 230.5 | -5.14% | 10,700 |
24-05-10 | 243 | +2.53% | 20,878 |
24-05-08 | 237 | +4.41% | 45,901 |
Delayed Quote Nasdaq Stockholm, May 15, 2024 at 03:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.25% | 506M | |
-13.12% | 19.25B | |
-40.05% | 2.96B | |
+23.79% | 1.96B | |
+1.29% | 1.69B | |
+28.27% | 1.27B | |
-14.61% | 982M | |
-20.31% | 913M | |
+2.50% | 801M | |
-24.78% | 630M |
- Stock Market
- Equities
- CEVI Stock